Applied Clinical Trials Editorial Staff

PPD and CISYS LifeSciences announced PPD’s implementation of Sequence WebEAS, a new Web-based event adjudication system, through a collaboration between the two companies.

Kayentis, a French software provider specialized in solutions for clinical trials, has chosen SFR Business Team for its M2M roaming in close to 250 countries.

INTERLAB and synlab have been successfully cooperating since 2004.

Admedus adopts the Medidata Clinical Cloud® to bring greater speed and efficiency to it’s genital herpes therapeutic vaccine study.

Implementation establishes foundation for sustainable growth in early phase clinical research

CRF Health, a provider of electronic Clinical Outcome Assessment (eCOA) solutions, has been selected as a partner of choice by two top tier pharmaceutical companies.

KMR Group reports that the duration of clinical trials continues to hold steady or increase despite ongoing efforts by biopharmaceutical companies to reduce cycle times.

U.S. Representative Billy Long has introduced legislation to update regulations guiding how drug manufacturers communicate product information.

Kowa Company Ltd, a Japanese pharmaceutical company, has migrated to Oracle Argus Cloud Service Global and Oracle Argus Cloud Japan.

The Jumpstarting Brain Tumor Drug Development Coalition (JBTDDC) announced a new consensus protocol for magnetic resonance imaging (MRI) in brain tumor clinical trials to help assess if a new treatment is effective.

Cloud-based solution allows investigators to simplify the development of clinical research protocols.

OmniComm Systems, a global provider of clinical data management technology, announced survey results from respondents that included 16 sponsor organizations and 13 contract research organizations (CROs).

The New England Journal of Medicine recently published results of a multi-center Phase II clinical trial, managed by CTMG.

BioClinica®, a clinical trials services and technology provider, announced the launch of the BioClinica eHealth Cloud™.

The identification of concomitant medication poses specific challenges in oncology data reporting.

With more than 60 percent of cancers in the United States occurring in people age 65 and older, the evidence base for treating older adults is sparse.

Epic Sciences announced an agreement with LabCorp to provide circulating tumor cell (CTC) technology and support oncology clinical trials in Asia through Covance Drug Development.

Cedars-Sinai announced that its Research for Her online registry that matches women with research studies and clinical trials.

Two Years Successful International Support for Clinical Trials Demonstrates Faster Enrollment, Over 95% Patient Retention Rates.

This new standalone solution is designed to meet the needs of early-stage drug discovery and development researchers.

Contract research organization ICON plc announced a partnership with Mereo BioPharma Group, a specialty biopharmaceutical company.

The collaboration increases the extent of which mHealth tools that can be used to support clinical research.

This new version release optimizes patient recruitment with study-specific prescreening workflows and a delivery platform that allows for self-administered cognitive assessments on any modality including tablet-based assessments

Strong Focus on New Research Collaborations; Up to 130 New Positions to Be Created.

The Pediatric Committee (PDCO) of the European Medicines Agency (EMA) has revised the current list of class waivers for medicines that are not required to submit a pediatric investigation plan.

LabCorp® announced that Covance Drug Development has relocated its clinical research unit in Dallas, TX, to a new, fit-for-purpose clinical research facility.

Collaboration Enables Use of Actionable, Patient-Generated Data in Clinical Trials from Extensive Range of mHealth Sensors, Wearables and Apps

Quorum Review IRB is introducing a comprehensive program that supports the needs of Phase I Healthy patients.